Doctor's Bio
Board Certifications
American Board of Urology
Affiliations
Emory
Education & Training
- Medical School: University of Chicago Pritzker School of Medicine
- Internship: University of California San Francisco School of Medicine
- Residency: University of California San Francisco School of Medicine
Fellowships
University of California San Francisco School of Medicine
Locations and Directions
Grady Memorial Hospital
Phone: (404) 616-1000
Location:
80 Jesse Hill Jr Drive SE
Atlanta, GA 30303
Publications
- Vasectomy reversal provides symptomatic relief in patients with Post-Vasectomy Pain Syndrome: A Systematic Review.
Lahiji R, Safdar B, Abdollahzadeh A, McKenzie J, Hong C, Braunschweig A, De Jesus-Escano M, Palmateer G, Patil D, Master VA, Cimmino CB
Urology practice. 2025;
PMID: 41104924 - Racial and Demographic Variables Are Associated with Accurate 24-Hour Urine Collection Completion and Results.
Lahiji R, Chu E, Morton EA, Ramacciotti LS, Kaufman R, Helman T, Agu GE, Harris M, Braunschweig A, Patel S, Mumford S, Hemige P, James B, Patil D, Hajiha M, Master V, Ogan K
Urology. 2025;
PMID: 41072807 - Erdafitinib in Patients with High- and Intermediate-risk Non-muscle-invasive Bladder Cancer: Final Analysis of THOR-2 Study.
Daneshmand S, Zaucha R, Catto JWF, Tran B, Master V, Lotan Y, Pignot G, Tubaro A, Shimizu N, Vasdev N, Lee EK, Procopio G, Galanternik F, Crow L, Deprince K, Naini V, Triantos S, Baig M, Zhu W, Maranchie JK
European urology. 2025;
PMID: 41062389 - Preoperative β2 Microglobulin Is a Prognostic Factor in Patients with Renal Cell Carcinoma and Normal Kidney Function.
Palmateer G, Nicaise EH, Goodstein T, Patil DH, Joshi SS, Narayan VM, Ogan K, Master VA
Research and reports in urology. 2025;
PMID: 41041609 - Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell Carcinoma.
Goodstein T, Goradia R, Srivastava A, Sood A, Dason S, Master VA, Singer EA
Clinical genitourinary cancer. 2025;
PMID: 40962570 - Proposed tripartite classification of T1 renal cell carcinoma: Comparison with current binary system.
Meagher MF, Musso G, Master V, Tanaka H, Capitanio U, Larcher A, Dabbas M, Patil D, Chen W, Puri D, Baker BH, Imtiaz S, Saitta C, Fukuda S, Kobayashi M, Salonia A, Briganti A, Fujii Y, Montorsi F, Derweesh IH
Urologic oncology. 2025;
PMID: 40903318 - Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma-An Observational Prospective Multicentre Diagnostic Test Cohort Study.
Dabestani S, Azawi NH, Campi R, Järvinen P, Nisen H, Capitanio U, Nielsen TK, Simone G, Rochester M, Green E, Fernandez-Pello S, Blick C, Porpiglia F, Ingels A, Bratulic S, Antonelli A, Hakimi AA, Jewett MAS, Ljungberg B, Bhindi B, Marconi L, Laird A, Stewart GD, Nair R, Lund L, Barber N, Master VA, Minervini A, Karam JA, Gatto F, Bex A
European urology oncology. 2025;
PMID: 40866172 - Development of a Health-related Quality of Life Questionnaire for Patients with Metastatic or Localized Renal Cell Carcinoma.
Bergerot CD, Cella D, Bergerot PG, Castro DV, Mercier BD, Nally E, Ali AA, Philip EJ, Hutson T, Bex A, Psutka SP, Rini B, Plimack ER, Grünwald V, Master V, Albiges L, Choueiri TK, Pal SK, Powles T
European urology oncology. 2025;
PMID: 40829999 - Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank.
Shapiro DD, Abel EJ, Albiges L, Battle D, Berg SA, Campbell MT, Cella D, Coleman K, Garmezy B, Geynisman DM, Hall T, Henske EP, Jonasch E, Karam JA, La Rosa S, Leibovich BC, Maranchie JK, Master VA, Maughan BL, McGregor BA, Msaouel P, Pal SK, Perez J, Plimack ER, Psutka SP, Riaz IB, Rini BI, Shuch B, Simon MC, Singer EA, Smith A, Staehler M, Tang C, Tannir NM, Vaishampayan U, Voss MH, Zakharia Y, Zhang Q, Zhang T, Carlo MI
Urologic oncology. 2025;43(11):639-653.
PMID: 40820078 - Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete Metastasectomy.
Ghasemzadeh A, Abel EJ, Karam JA, Spiess PE, Peyton CC, Manley BJ, Sirard RB, Robertson N, Ellis EE, Cotta BH, Patel KR, Nicaise E, Jani A, Sexton WJ, Patil D, Allen GO, Matin SF, Master VA, Shapiro DD
The Journal of urology. 2025;214(5):521-529.
PMID: 40763351
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.